Kikuo Sugimoto
FMC Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kikuo Sugimoto.
European Journal of Pharmacology | 1996
Je-Tae Woo; Kohji Yamaguchi; Takahiro Hayama; Takeo Kobori; Sanae Sigeizumi; Kikuo Sugimoto; Kiyosi Kondo; Tomoko Tsuji; Yasuo Ohba; Kahori Tagami; Koji Sumitani
The suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption was examined in vitro and in vivo. This synthetic peptidyl aldehyde was found to be a potent and selective cathepsin L inhibitor in our screening for cysteine protease inhibitors. In the pit formation assay with unfractionated rat bone cells, 1.5 nM of this compound markedly inhibited parathyroid hormone-stimulated osteoclastic bone resorption. In addition, intraperitoneal administration of this peptidyl aldehyde (2.5-10 mg/kg) for 4 weeks suppressed bone weight loss dose dependently in the ovariectomized mouse, experimental model of osteoporosis. Hydroxyproline measurement of the decalcified femurs from these ovariectomized mice suggested that this compound acts as a bone resorption suppressor through the inhibition of collagen degradation.
Bioorganic & Medicinal Chemistry Letters | 1995
Je-Tae Woo; Sanae Sigeizumi; Kohji Yamaguchi; Kikuo Sugimoto; Takeo Kobori; Tomoko Tsuji; Kiyosi Kondo
Abstract A series of peptidyl aldehyde derivatives were synthesized and tested for their inhibitory effects on several cysteine proteases and a serine protease. These componds showed no inhibition for α-chymotrypsin at the concentration less than 1000 ng/ml, while they exhibited prominent inhibition for calpain II and cathepsins, especially cathepsin L.
Bioorganic & Medicinal Chemistry Letters | 2003
Minoru Taguchi; Kikuo Sugimoto; Kenichi Goda; Tomoko Akama; Kyoko Yamamoto; Taizo Suzuki; Yasumitsu Tomishima; Mariko Nishiguchi; Koshi Arai; Kenzo Takahashi; Takeo Kobori
To search for neutral sphingomyelinase inhibitors we designed and synthesized hydrolytically stable analogues of sphingomyelin. The novel compounds 8 and 9 which were replaced the phosphodiester moiety of sphingomyelin with the carbamate moiety showed inhibitory activity with an IC(50) value of micro M on neutral sphingomyelinase in rat brain microsomes. Compound 8i showed a selective neutral sphingomyelinase inhibitory activity.
Tetrahedron Letters | 1994
Kunikazu Sakai; Kikuo Sugimoto; Sanae Shigeizumi; Kiyosi Kondo
Abstract A new dichlorination procedure of CC double bond was developed with hexachloroethane as chlorinating agent and RuCl2(PPh3)3 as catalyst. The reaction is highly selective for CC double bond; other functional groups are unaffected by these conditions.
Journal of Applied Polymer Science | 1991
Yu Nagase; Kikuo Sugimoto; Yuriko Takamura; Kiyohide Matsui
Journal of Applied Polymer Science | 1986
Kiyohide Matsui; Etsuko Tobita; Kikuo Sugimoto; Kiyosi Kondo; Toru Seita; Akira Akimoto
Bioorganic & Medicinal Chemistry Letters | 2003
Minoru Taguchi; Kenichi Goda; Kikuo Sugimoto; Tomoko Akama; Kyoko Yamamoto; Taizo Suzuki; Yasumitsu Tomishima; Mariko Nishiguchi; Koshi Arai; Kenzo Takahashi; Takeo Kobori
Pesticide Science | 1980
Kiyosi Kondo; Toshiyuki Takashima; Akira Negishi; Kiyohide Matsui; Tamotsu Fujimoto; Kikuo Sugimoto; Charles E. Hatch; Jonathan S. Baum
Archive | 1996
Kenichi Goda; Takeo Kobori; Kikuo Sugimoto
Archive | 1979
Kiyoshi Kondo; Akira Negishi; Kikuo Sugimoto